Accepted answer
At 8 mg/mL a 0.25 mg draw is 3.1 units on a U-100 barrel and a 2.4 mg draw is 30. Those two numbers decide it, because the concentration is only sensible relative to the smallest and largest volumes you will actually measure with it. 3.1 units is too little of the scale to read honestly — half a graduation is 16 per cent of that dose — so going lower in concentration buys resolution you cannot get back after reconstitution. The other consideration is time: a vial you will finish in a fortnight can be concentrated, and a vial you will draw from for months should be split at reconstitution instead.
The short version: more diluent means a lower concentration, a larger volume per dose and a finer reading; less means the opposite.
Dead-space loss scales with the number of draws, not with the concentration, so a lower concentration spread over more draws loses proportionally less of the total peptide.
More usefully, vial headspace is the hard constraint. A nominal 2 mL vial typically holds a little over 2 mL to the shoulder; adding 3 mL is not an option and attempting it wastes the lot.
Published content assay results across the independent testing services show nominal and measured content differing by one to ten per cent, which makes content the dominant term in dose error.
The caveat is that this arithmetic assumes the vial contains what the label says, and without a content assay it is precise about an unknown quantity.
Measure a volume you can actually measure. Round numbers, real syringes.